Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma
- DOI
- 10.1093/neuonc/noy053
- Published
- 2018-04-05
- Container
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/neuonc/noy053,
title = {Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma},
author = {Benjamin M Ellingson and Lauren E Abrey and Sarah J Nelson and Timothy J Kaufmann and Josep Garcia and Olivier Chinot and Frank Saran and Ryo Nishikawa and Roger Henriksson and Warren P Mason and Wolfgang Wick and Nicholas Butowski and Keith L Ligon and Elizabeth R Gerstner and Howard Colman and John de Groot and Susan Chang and Ingo Mellinghoff and Robert J Young and Brian M Alexander and Rivka Colen and Jennie W Taylor and Isabel Arrillaga-Romany and Arnav Mehta and Raymond Y Huang and Whitney B Pope and David Reardon and Tracy Batchelor and Michael Prados and Evanthia Galanis and Patrick Y Wen and Timothy F Cloughesy},
year = {2018},
journal = {Neuro-Oncology},
doi = {10.1093/neuonc/noy053},
url = {https://doi.org/10.1093/neuonc/noy053}
}RIS
TY - JOUR TI - Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma AU - Benjamin M Ellingson AU - Lauren E Abrey AU - Sarah J Nelson AU - Timothy J Kaufmann AU - Josep Garcia AU - Olivier Chinot AU - Frank Saran AU - Ryo Nishikawa AU - Roger Henriksson AU - Warren P Mason AU - Wolfgang Wick AU - Nicholas Butowski AU - Keith L Ligon AU - Elizabeth R Gerstner AU - Howard Colman AU - John de Groot AU - Susan Chang AU - Ingo Mellinghoff AU - Robert J Young AU - Brian M Alexander AU - Rivka Colen AU - Jennie W Taylor AU - Isabel Arrillaga-Romany AU - Arnav Mehta AU - Raymond Y Huang AU - Whitney B Pope AU - David Reardon AU - Tracy Batchelor AU - Michael Prados AU - Evanthia Galanis AU - Patrick Y Wen AU - Timothy F Cloughesy PY - 2018 JO - Neuro-Oncology DO - 10.1093/neuonc/noy053 UR - https://doi.org/10.1093/neuonc/noy053 ER -
APA
Ellingson, B. M., Abrey, L. E., Nelson, S. J., Kaufmann, T. J., Garcia, J., Chinot, O., Saran, F., Nishikawa, R., Henriksson, R., Mason, W. P., Wick, W., Butowski, N., Ligon, K. L., Gerstner, E. R., Colman, H., Groot, J. D., Chang, S., Mellinghoff, I., Young, R. J., Alexander, B. M., Colen, R., Taylor, J. W., Arrillaga-Romany, I., Mehta, A., Huang, R. Y., Pope, W. B., Reardon, D., Batchelor, T., Prados, M., Galanis, E., Wen, P. Y., & Cloughesy, T. F. (2018). Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noy053
Source records
- crossref · retrieved 2026-09-26T22:41:33.771Z